Category Medicine and Healthcare
Press Release
Interactive Strength Inc. (Nasdaq: TRNR) Completes Acquisition of Wattbike, Creating a Diversified Global Fitness Platform on Track for More than $75 Million in Pro Forma 2025 Revenue
Wattbike acquisition is the latest milestone in transformational strategy and the Sportstech acquisition is on track to close in the third quarter TRNR confirms guidance of more than $75 million in pro forma 2025 revenue and profitability in fourth quarter TRNR's $55 million Digital Asset Treasury is actively purchasing $FET cryptocurrency Read More
Press Release
MDelite's iProElite Multi-Modality Platform Brings Scalable, Customizable Care to Aesthetic and Vision Practices
Built by industry veterans, the iProElite system offers multi-modality flexibility, real-world support, and clinical protocols designed to grow with your practice. Read More
Press Release
Medical Care Technologies Inc. (OTC Pink:MDCE) Launches Back-to-Back Michael Jordan High Value Memorabilia Auctions
The GOAT Collection features game-worn memorabilia from Michael Jordan, LeBron James, and Kobe Bryant; The Grail Collection to follow with high value assets from sports history's most iconic legends. Read More
Press Release
DEA BUSTED!! While Chinese Marijuana Cartels Spread Right Under DEA's Nose, FDA CANNABIS RESEARCH BLOCKED
While Chinese cartels built a marijuana empire across at least six states, MMJ-a Rhode Island-based company with FDA orphan drug status-was left to rot in a bureaucratic black hole engineered by DEA Diversion officials Matthew Strait, Thomas Prevoznik, Anne Milgram and Aarathi Haig. Read More
Press Release
Heart Freedom Supplement Introduces Structured 3-12 Month Protocols to Optimize Cardiovascular Function Using Natural Botanicals
Clinically-informed routines backed by garlic, hawthorn berry, and hibiscus highlight Heart Freedom's botanical approach to sustained blood pressure support, circulation enhancement, and heart health integration in 2025. Read More
Press Release
Herz P1 Smart Ring Reveals Full Specs: 10+ Biometric Sensors, 7-Day Battery, Military-Grade Build
The 2025 launch of the Herz P1 Smart Ring introduces a sleek, all-weather wearable that tracks sleep, stress, heart rate variability, blood oxygen, and temperature - delivering continuous health insights through a durable, low-maintenance, app-connected device. Read More
Press Release
Protagonist Announces Nomination of PN-477, an Oral and Injectable GLP-1R, GIPR, and GCGR Triple Agonist Peptide Development Candidate for Obesity
A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic peptide (GIP), and glucagon (GCG) receptors Company will also develop a subcutaneous version, PN-477sc, as a once-weekly injection IND-enabling studies underway, with Phase I study initiation expected in 2Q26 Webcast and conference call to be held today at 4:30 pm ET Read More
Press Release
Proof-of-Concept Results Show Jaguar Health's Crofelemer Reduced Total Parenteral Nutrition in Third Intestinal Failure Orphan Disease Patient
As recently announced, initial proof-of-concept results from this ongoing investigator-initiated trial (IIT) show crofelemer reduced the required total parenteral nutrition in the first participating microvillus inclusion disease (MVID) patient by up to 27% and in the first participating short bowel syndrome patient by up to 12.5% The first two patients in this IIT were taken off crofelemer after 12 weeks of treatment for a period intended to last 30 days, per the study protocol, but were promptly placed back on daily crofelemer treatment because their symptoms worsened Company strategy: Seek business development partnerships for license to develop and commercialize Jaguar's intestinal failure products, resulting in non-dilutive funding for Jaguar Read More
Press Release
US MedTech Disruptor OIC International Expands Into Asia, Central, and South America With Affordable Trauma Innovation
OIC International brings modular trauma systems to underserved global markets, advancing surgical care through innovation, accessibility, and regional collaboration. Read More
Press Release
Ainos Completes Stock Consolidation, Enters New Phase of Global Expansion and Technology Commercialization
Partners With ASE to Scale AI Nose Deployment and Set New Standard in Intelligent Sensing Achieves Strategic Inflection Point in 1H 2025 with Partnerships and Operational Breakthroughs Read More
Press Release
MIRA Reports Up to 30% Weight Loss and Reversal of High-Calorie and Nicotine Cravings in an Animal Model of Obesity and Craving Using SKNY-1, a Drug Candidate Under Definitive Agreement for Acquisition
Oral therapy designed to minimize CNS side effects shows dual activity in weight loss and smoking cessation models without muscle loss Read More
Press Release
DEA Diversion Officials Scrambling For DOGE Retirement: Corrupt Bureaucrats Blocked Medical Cannabis Research While Patients Suffered
Retirements Reported in DEA's DIVERSION as "DOGE CASUALTIES". DEA Faces Scrutiny Over Delays in Medical Cannabis Research. As MMJ BioPharma Cultivation unleashes a legal reckoning, the DEA's unconstitutional Administrative Law system collapses under Supreme Court rulings-forcing Department Of Justice to retreat, leaving DEA officials scrambling for cover. DEA diversion officials will be remembered on its "wall of DISHONOR" for blocking marijuana medicine to suffering patients in need. Read More
Press Release
Visiultra Eye Health Supplement Ignites 2025 Surge as Vision Strain From Screens and Aging Hits Critical Mass
Fueled by screen fatigue, blue light exposure, and age-related eye concerns, Visiultra's science-backed formula featuring lutein, zeaxanthin, and astaxanthin is gaining traction among adults seeking daily vision support and long-term ocular clarity in 2025. Read More
Press Release
AI and Advanced Analytics Drive Transformation in Physician Revenue Cycle Management: Black Book's 2025 Vendor Rankings by Practice Size and Specialty
Survey findings underscore significant improvements in medical practice denial management, patient engagement, and operational efficiency driven by advanced technologies. Read More
Press Release
Ainos and ASE Technology Holding Broaden Strategic Partnership to Target Deploy Up to 15,000 AI Nose Across Key Sites
Relationship Broadens Scope to Key ASE and SPIL Facilities with Multi-Phase Deployment Milestone Positions ASEH and Ainos as First-Mover in AI-Powered Scent Intelligence for the Semiconductor Industry Read More
Press Release
The Connection Between Alcohol Use and Psychiatric Conditions
Earn Continuing Education credits and learn about the complex interplay between alcohol use disorder (AUD) and common co-occurring psychiatric conditions, including bipolar disorder, major depressive disorder, and generalized anxiety disorder. Read More
Press Release
ProXental Under Review: A Natural Dental Gel for Gum Appearance and Oral Freshness
How ProXental's essential oil and antioxidant dental gel supports gum appearance and oral freshness, with science-backed insights, ingredient analysis, daily usage plans, and long-term wellness integration strategies for 2025. Read More
Press Release
Best Cardiovascular Supplement Under Review: Natural Heart Health Supplement by Most Trusted Brand
Cardio Shield, developed by Apollo Research, emerges as the leading cardiovascular supplement of 2025 with a clinically inspired, natural formula designed to support blood pressure, circulation, and heart function - backed by real user results, scientific validation, and a 180-day risk-free guarantee. Read More
Press Release
PillSafe Taps Healthcare Veteran Lon G. von Hurwitz to Lead Brand Modernization and Commercial Strategy
Lon G. von Hurwitz, who will serve as chief strategist and senior advisor, brings 30-plus years of leadership experience in healthcare innovation, marketing, and public health initiatives and will guide efforts to bring the smart medication delivery technology to market in early 2026. Read More
Press Release
Jaguar Health to Pursue Approval of Canalevia in European Union for Treatment of General Diarrhea in Dogs
Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for treatment of chemotherapy-induced diarrhea in dogs Jaguar is exploring the possibility of approval of Canalevia for treatment of general diarrhea in dogs in the EU based on the statistically significant data from a completed study Diarrhea is one of the most common reasons owners bring their dog to the veterinarian and the second most common reason for visits to the veterinary emergency hospital, yet there are currently no FDA-approved drugs to treat general diarrhea in dogs Company strategy: In discussions with multiple potential animal health company partners to collaborate to bring Canalevia to regulatory approval and commercialization for general diarrhea globally Read More
Press Release
Robert F. Kennedy Jr. Reveals Sweeping FDA Reform Agenda as HHS Secretary in 2025
The ‘Make America Healthy Again' initiative challenges pharmaceutical influence, promotes access to natural therapies, and proposes regulatory changes to FDA oversight, food safety, and vaccine review protocols. Read More
Press Release
Interactive Strength Inc. (Nasdaq:TRNR) Announces 1-for-10 Reverse Split
Reverse Split Becomes Effective Friday, June 27, 2025 Shareholder- and Board-Approved Action Reduces Shares Outstanding to 1.4 million from 13.9 million, Expected to Ensure Continued Compliance with Nasdaq Listing Requirements Read More
Press Release
